State Codes and Statutes

Statutes > Kentucky > 217-00 > 814

Download pdf
Loading PDF...


217.814 Definitions for KRS 217.815 to 217.826. The following words and phrases, as used in KRS 217.815 to 217.826, shall have the <br>following meanings, unless the context requires otherwise: <br>(1) &quot;Brand name&quot; means the name that a manufacturer of a drug or pharmaceutical places on the container thereof at the time of packaging. (2) &quot;Generic name&quot; means the chemical or established name of a drug or pharmaceutical. (3) &quot;Practitioner&quot; has the same meaning as in KRS 217.015. <br>(4) &quot;Pharmacist&quot; means any person licensed as such by the Kentucky Board of Pharmacy. (5) &quot;Equivalent drug product&quot; means a product with the same generic name, active ingredients, strength, quantity and dosage form as the drug product identified in a <br>prescription. (6) &quot;Board&quot; means the Kentucky Board of Pharmacy. <br>(7) &quot;Nonequivalent drug product formulary&quot; means a formulary of drugs, drug products, and dosage formulations for which there are no equivalent drugs, drug <br>products, or dosage formulations and which have been determined to be <br>noninterchangeable or to have actual or potential bioequivalency problems by the <br>United States Food and Drug Administration and are contained in a drug <br>bioequivalence problems list as published in the United States Food and Drug <br>Administration publication entitled &quot;Approved prescription drug products with <br>therapeutic equivalence evaluations&quot; with supplements. (8) &quot;Dosage formulation&quot; shall include, but not be limited to, those specific dosage forms which, by the nature of their physical manufacture are deemed to be <br>nonequivalent to other similar formulations such as controlled release tablets, <br>aerosol-nebulizer drug delivery systems and enteric coated oral dosage forms. Effective: June 24, 2003 <br>History: Amended 2003 Ky. Acts ch. 51, sec. 2, effective June 24, 2003. -- Amended 1982 Ky. Acts ch. 399, sec. 1. -- Created 1972 Ky. Acts ch. 126, sec. 1.

State Codes and Statutes

Statutes > Kentucky > 217-00 > 814

Download pdf
Loading PDF...


217.814 Definitions for KRS 217.815 to 217.826. The following words and phrases, as used in KRS 217.815 to 217.826, shall have the <br>following meanings, unless the context requires otherwise: <br>(1) &quot;Brand name&quot; means the name that a manufacturer of a drug or pharmaceutical places on the container thereof at the time of packaging. (2) &quot;Generic name&quot; means the chemical or established name of a drug or pharmaceutical. (3) &quot;Practitioner&quot; has the same meaning as in KRS 217.015. <br>(4) &quot;Pharmacist&quot; means any person licensed as such by the Kentucky Board of Pharmacy. (5) &quot;Equivalent drug product&quot; means a product with the same generic name, active ingredients, strength, quantity and dosage form as the drug product identified in a <br>prescription. (6) &quot;Board&quot; means the Kentucky Board of Pharmacy. <br>(7) &quot;Nonequivalent drug product formulary&quot; means a formulary of drugs, drug products, and dosage formulations for which there are no equivalent drugs, drug <br>products, or dosage formulations and which have been determined to be <br>noninterchangeable or to have actual or potential bioequivalency problems by the <br>United States Food and Drug Administration and are contained in a drug <br>bioequivalence problems list as published in the United States Food and Drug <br>Administration publication entitled &quot;Approved prescription drug products with <br>therapeutic equivalence evaluations&quot; with supplements. (8) &quot;Dosage formulation&quot; shall include, but not be limited to, those specific dosage forms which, by the nature of their physical manufacture are deemed to be <br>nonequivalent to other similar formulations such as controlled release tablets, <br>aerosol-nebulizer drug delivery systems and enteric coated oral dosage forms. Effective: June 24, 2003 <br>History: Amended 2003 Ky. Acts ch. 51, sec. 2, effective June 24, 2003. -- Amended 1982 Ky. Acts ch. 399, sec. 1. -- Created 1972 Ky. Acts ch. 126, sec. 1.

State Codes and Statutes

State Codes and Statutes

Statutes > Kentucky > 217-00 > 814

Download pdf
Loading PDF...


217.814 Definitions for KRS 217.815 to 217.826. The following words and phrases, as used in KRS 217.815 to 217.826, shall have the <br>following meanings, unless the context requires otherwise: <br>(1) &quot;Brand name&quot; means the name that a manufacturer of a drug or pharmaceutical places on the container thereof at the time of packaging. (2) &quot;Generic name&quot; means the chemical or established name of a drug or pharmaceutical. (3) &quot;Practitioner&quot; has the same meaning as in KRS 217.015. <br>(4) &quot;Pharmacist&quot; means any person licensed as such by the Kentucky Board of Pharmacy. (5) &quot;Equivalent drug product&quot; means a product with the same generic name, active ingredients, strength, quantity and dosage form as the drug product identified in a <br>prescription. (6) &quot;Board&quot; means the Kentucky Board of Pharmacy. <br>(7) &quot;Nonequivalent drug product formulary&quot; means a formulary of drugs, drug products, and dosage formulations for which there are no equivalent drugs, drug <br>products, or dosage formulations and which have been determined to be <br>noninterchangeable or to have actual or potential bioequivalency problems by the <br>United States Food and Drug Administration and are contained in a drug <br>bioequivalence problems list as published in the United States Food and Drug <br>Administration publication entitled &quot;Approved prescription drug products with <br>therapeutic equivalence evaluations&quot; with supplements. (8) &quot;Dosage formulation&quot; shall include, but not be limited to, those specific dosage forms which, by the nature of their physical manufacture are deemed to be <br>nonequivalent to other similar formulations such as controlled release tablets, <br>aerosol-nebulizer drug delivery systems and enteric coated oral dosage forms. Effective: June 24, 2003 <br>History: Amended 2003 Ky. Acts ch. 51, sec. 2, effective June 24, 2003. -- Amended 1982 Ky. Acts ch. 399, sec. 1. -- Created 1972 Ky. Acts ch. 126, sec. 1.